Table 3 Distribution of the involved fascial space
From: Clinical utility of procalcitonin in severe odontogenic maxillofacial infection
Fascial space | Sepsis | Non-sepsis | Total |
|---|---|---|---|
Submasseteric | 9 | 18 | 27 (19.4) |
Submandibular | 7 | 16 | 23 (16.5) |
Pterygomandibular | 7 | 14 | 21 (15.1) |
Sublingual | 4 | 12 | 16 (11.5) |
Buccal | 3 | 11 | 14 (10.1) |
Submental | 4 | 10 | 14 (10.1) |
Infratemporal | 5 | 3 | 8 (5.8) |
Lateral pharyngeal | 2 | 5 | 7 (5.0) |
Superficial temporal | 4 | 1 | 5 (3.6) |
Canine | 0 | 4 | 4 (2.9) |
Total | 45 | 94 | 139 (100) |